FDA Regulatory Tuesday, November 17, 2026 +0.40 Positive

FDA Approves Lifesaving Medicine for Infantile-Onset NPC

The FDA approved Lembaz injection, the first treatment demonstrated to help patients with infantile-onset Niemann-Pick disease type C live longer.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed